Dementia management: Regulations, rules, and research

Journal of the American Medical Directors Association

Volumn 4, Issue 4 SUPPL., 2003, Pages

  Tune, Larry E ^a   Porsteinsson, Anton ^a   Weinberg, Andrew ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CAPTOPRIL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CIMETIDINE; CODEINE; COTRIMOXAZOLE; DIGOXIN; DIPYRIDAMOLE; DONEPEZIL; FUROSEMIDE; GALANTAMINE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; ISOSORBIDE; LITHIUM; NEUROLEPTIC AGENT; NIFEDIPINE; PREDNISOLONE; RANITIDINE; RISPERIDONE; RIVASTIGMINE; SERTRALINE; THEOPHYLLINE; UNINDEXED DRUG; VALPROIC ACID; WARFARIN;

BEHAVIOR DISORDER; CLINICAL TRIAL; CONFERENCE PAPER; DEMENTIA; DRUG CHOICE; DRUG INDICATION; DRUG MONITORING; ENVIRONMENTAL FACTOR; HUMAN; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; MENTAL DISEASE; NEUROPROTECTION; PRACTICE GUIDELINE; SYMPTOMATOLOGY; TREATMENT PLANNING;

EID: 0042133234     PISSN: 15258610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-8610(04)70360-6     Document Type: Conference Paper

References (10)

1. G Chen WZ Zeng PX Yuan The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS J Neurochem 72 1999 879 882
2. LH Deutsch FW Bylsma BW Rovner Psychosis and physical aggression in probable Alzheimer's disease Am J Psychiatry 48 1991 1159 1163
3. WC Drevets EH Rubin Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type Biol Psychiatry 25 1989 39 48
4. JM Engelhart MI Geerlings A Ruitenberg Dietary intake of antioxidants and risk of Alzheimer disease JAMA 287 2002 3223 3229
5. IR Katz DV Jeste JE Mintzer Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial. Risperidone Study Group J Clin Psychiatry 60 1999 107 115
6. JA Luchsinger MX Tang S Shea Antioxidant vitamin intake and risk of Alzheimer disease Arch Neurol 60 2003 203 208
7. DQ McManus LA Arvanitis BB Kowalcyk Quetiapine, a novel antipsychotic: Experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group J Clin Psychiatry 60 1999 292 298
8. M Rosler R Anand A Cicin-Sain Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International randomised controlled trial Br Med J 318 1999 633 638
9. JS Street WS Clark KS Gannon Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial. The HGEU Study Group Arch Gen Psychiatry 57 2000 968 976
10. PN Tariot PR Solomon JC Morris A 5-month, randomized, placebo-controlled trial of galantamine in AD: The Galantamine USA-10 Study Group Neurology 54 2000 2269 2276